| 000 | 00892 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517164830.0 | ||
| 264 | 0 | _c20180917 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(17)31962-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoyd, Mark A | |
| 245 | 0 | 0 |
_aLong-acting injectable ART: next revolution in HIV? _h[electronic resource] |
| 260 |
_bLancet (London, England) _c09 2017 |
||
| 300 |
_a1468-1470 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAnti-HIV Agents |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aCooper, David A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 390 _gno. 10101 _gp. 1468-1470 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(17)31962-1 _zAvailable from publisher's website |
| 999 |
_c27409564 _d27409564 |
||